Euclidean Capital LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$266.1B
Holdings
11
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INDAISHARES TR | 2,425,144 | $124.8B | 46.91% | |
| 2 | VEUVANGUARD INTL EQUITY INDEX F | 1,991,884 | $120.8B | 45.40% | |
| 3 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $5.7B | 2.16% | |
| 4 | ORICORIC PHARMACEUTICALS INC | 989,410 | $5.5B | 2.07% | |
| 5 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $2.9B | 1.08% | |
| 6 | SPYSPDR S&P 500 ETF TR | 4,104 | $2.3B | 0.86% | |
| 7 | ALECALECTOR INC | 1,307,858 | $1.6B | 0.60% | |
| 8 | SRZNSURROZEN INC | 87,696 | $1.0B | 0.38% | |
| 9 | RAPTEURRAPT THERAPEUTICS INC | 657,899 | $802.6M | 0.30% | |
| 10 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $579.1M | 0.22% | |
| 11 | SRZNWSURROZEN INC | 170,833 | $5.1M | 0.00% |